Nanotechnology in Diagnosis and Treatment of Diabetes Mellitus: Review

Abstract

Customary techniques for diabetes management require steady and tedious glucose monitoring (GM) and insulin infusions, affecting quality of life. The worldwide diabetic population is required to increment to 439 million, with roughly US$490 billion in medical services consumptions by 2030, forcing a huge trouble on medical care systems around the world. Ongoing advances in nanotechnology have arisen as promising elective methodologies for the management of diabetes. For instance, implantable nano sensors are being created for nonstop GM, new nanoparticle (NP)- based imaging approaches that evaluate subtle changes in β cell mass can encourage early diagnosis, and nano technology-based insulin delivery strategies are being investigated as novel treatments. Here, we give an all-encompassing rundown of this quickly propelling field gathering all viewpoints relating to the management of diabetes.